This study is examining the effectiveness of a device-assisted practice of activities of daily living (ADL) to treat disability in stroke survivors. The main outcome to be measured will be the change in movement of the affected arm/hand. This study is being conducted in Illinois, US.
A stroke happens when the blood flow to the brain is cut off. Brain cells stop receiving oxygen and begin to die. The abilities controlled by these cells are lost causing symptoms such as arm paralysis. Performing daily living activities becomes a challenge for these patients. This affects their quality of life and of their caregivers. Practicing activities of daily living during treatment might improve the recovery of these patients.
This study is examining the effectiveness of a device-assisted practice of activities of daily living (ADL) to treat disability in stroke survivors. The main outcome to be measured will be the change in the movement of the affected arm/hand.
Who are they looking for?
This trial is recruiting 60 participants with mild to severe stroke. These patients must have a one arm paralysis, be able to move the arm up and open their hand. Must be able to do MRI, must have healthy skin on the affected arm and be able to sit for 1 hour. Patients must be able to attend sessions 3 times a week for 8 weeks.
These patients must be undergoing other types of physical rehabilitation. Must not have any other severe disease (including brain disease), mental disease or seizure. Must not have had treatment with injections on the affected arm within the last 12 months. Must not be participating in another trial, must not have any other arm disorder, currently using oxygen or arm amputation. Female participants must not be pregnant or breastfeeding.
How will it work
The trial consists of 24 sessions of 2 hours, 3 times per week for 8 weeks. Patients will be assigned to receive ADL with and without a robotic hand (two groups). Participants will be seated with straps across the chest and waist. The training technicians will stretch the affected arm for 15 minutes. Participants will be followed-up for 3 months.
The main outcome will be assessed by measuring the change in arm/hand movement.